Who named it?Search
blank
blank
blank
 
blank
blank
blank
blank
blank
blank
 
Disclaimer:
Whonamedit.com does not give medical advice.
This survey of medical eponyms and the persons behind them is meant as a general interest site only. No information found here must under any circumstances be used for medical purposes, diagnostically, therapeutically or otherwise. If you, or anybody close to you, is affected, or believe to be affected, by any condition mentioned here: see a doctor.

A recommendation:
Hypography is an open community about science and all things related

 

Margaret Anne Keller

American paediatrician, born 1942.



Associated eponyms:
Kaveggia's syndrome
A possibly independent entity of severe mental retardation, spastic disturbances of movements with athetoid cerebral palsy, dwarfism and facial dysmorphies.

Opitz-Kaveggia syndrome
Distinct disease picture with mental retardation, short stature, joint contractures, muscular hypotony, imperforate or displaced anus, macrocephaly, and characteristic facial dysmorphy, etc.





Biography:
Margaret Anne E. Keller graduated from the Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, and served her residency in pediatrics at the University of California Sand Diego, Medical Centre. From 1975 to 1977 she was a Fellow in Pediatric Infectious Diseases at USCD, San Diego, California, and from 1976 to 1978 a Fellow in Pediatric Infectious Diseases and Immunology, Harbor-UCLA Medical Center, Torrance, California. From 1978 to 1985 she was Assistant Professor of Pediatrics, Divisions of Infectious Diseases and Immunology, UCLA School of Medicine, Harbor-UCLA Medical Center, Torrance, California. In 2001 she became Present Professor of Pediatrics, Divisions of Infectious Diseases and Immunology, UCLA School of Medicine, Harbor-UCLA Medical Center, Torrance, California.

Her research focus has been:
Magnetic resonance spectroscopy of the brain in HIV-infected patients.
Clinical trials in HIV –infected children, adolescents, and pregnant woman including pharmacokinetics of antiretroviral drugs and prevention of maternal to infant transmission of HIV.

Information above is from the homepage of Harbor-UCLA Pediatrics.

We thank Patrick Jucker-Kupper, Switzerland, for information submitted.




Bibliography:
  • Hyperbaric oxygen in the therapy of experimental hemorrhagic shock.
    Y. G. Jacobson, A. J. Defalco, E. D. Mundth, M. A Keller.
    Surgical Forum, Chicago, 1965, 16: 15-17.

  • Editorial: Diabetic ketosis and acidosis: The continuous infusion of low doses of insulin.
    A. Kaufman, M. A. Keller, William Leo Nyhan.
    The Journal of Pediatrics, St. Louis, November 1975, 87 (5): 846-848.

  • A new syndrome of mental deficiency with craniofacial, limb, and anal abnormalities.
    Margaret A. Keller, Kenneth L. Jones, William L. Nyhan, Uta Francke, Barbara Dixson.
    The Journal of Pediatrics, St. Louis, April 1976, 88 (4 pt. 1): 589-591.

  • Systemic candidiasis in infants: a case presentation and literature review.
    M. A. Keller, B. B. Sellers Jr, M. E. Melish, G. W. Kaplan, K. E. Miller, S. A. Mendoza.
    American Journal of Diseases of Children, Chicago, November 1977, 131 (11): 1260-1263.

  • Adenovirus infection and pertussis-like syndrome.
    M. A Keller.
    The Journal of Pediatrics, St. Louis, January 1980, 96 (1): 177-178.

  • Breast milk lymphocyte response to K1 antigen of Escherichia coli.
    M. A. Keller, J. L. Turner, J. A. Stratton, M. E. Miller.
    Infection and Immunity, Bethesda, March 1980, 27 (3): 903-909.

  • Etiology of pertussis syndrome.
    M. A. Keller, R. Aftandelians, J. D. Connor.
    Pediatrics, July 1980, 66 (1): 50-55.

  • Lymphokine production by human milk lymphocytes.
    M. A. Keller, R. M. Kidd, Y. J. Bryson, J. L. Turner, J. Carter.
    Infection and Immunity, Bethesda, May 1981, 32 (2): 632-636.

  • Letters to the Editor. Margaret A. Keller MD.
    Pediatrics, July 1981, 68 (1): 149.

  • Wound botulism in pediatrics.
    M. A. Keller, V. H. Miller, C. D. Berkowitz, R. N. Yoshimori.
    American Journal of Diseases of Children, Chicago, April 1982, 136 (4): 320-322.

  • IgE and IgD in human colostrum and plasma.
    S. L. Bahna, M. A. Keller, D. C. Heiner.
    Pediatric Research, August 1982, 16 (8): 604-607.

  • CT and intracranial manifestations of otorhinologic disease.
    M. A. Keller, R. C. Holgate, B. M. McClarty.
    The Journal of Otolaryngology, December 1982, 11 (6): 407-410.

  • Unusual skin manifestation of brucellosis.
    B. M. Gee-Lew, E. A. Nicholas, F. M. Hirose, R. N. Yoshimori, M. A Keller.
    Archives of Dermatology, Chicago, January 1983, 119 (1): 56-58.

  • Local production of IgG4 in human colostrum.
    M. A. Keller, D. C. Heiner, R. M. Kidd, A. S. Myers.
    The Journal of Immunology, Baltimore, April 1983, 130 (4): 1654-1657.

  • Lymphocyte-derived chemotactic factor production by neonatal lymphocytes.
    M. A. Keller, R. M. Kidd, R. D. Leake, S. L. Everett.
    Pediatric Research, October 1983, 17 (10): 799-802.

  • Radiological case of the month. Asymptomatic calcified pulmonary tuberculosis.
    H. D. Bui, M. A. Keller, S. A. Jayich, R. J. Nelson, D. P. Harley, R. S. Lachman, L. W. Young.
    American Journal of Diseases of Children, Chicago, January 1984, 138 (1): 91-93.

  • IgD in human colostrum.
    M. A. Keller, D. C. Heiner, A. S. Myers, D. M. Reisinger.
    Pediatric Research, January 1985, 19 (1): 122-126.

  • T cell subsets in human colostrum.
    M. A. Keller, J. Faust, L. J. Rolewic, D. D. Stewart.

    Journal of Pediatric Gastroenterology and Nutrition, May-June 1986, 5 (3): 439-443.

  • Echovirus 11 arthritis in a patient with X-linked agammaglobulinemia.
    B. K. Ackerson, R. Raghunathan, M. A. Keller, R. H. Bui, P. R. Phinney, D. T. Imagawa.
    The Pediatric Infectious Disease Journal, Baltimore, May 1987, 6 (5): 485-488.

  • Transfer of tuberculin immunity from mother to infant.
    M. A. Keller, A. L. Rodgriguez, S. Alvarez, N. C. Wheeler, D. Reisinger.

    Pediatric Research, September 1987, 22 (3): 277-281.

  • IgG4 in human colostrum and human milk: continued local production or selective transport from serum.
    M. A. Keller, L. Gendreau-Reid, D. C. Heiner, A. Rodriguez, J. A. Short.
    Acta paediatrica Scandinavica, Stockholm, January 1988, 77 (1): 24-29.

  • A predominant idiotype independent of specificity, or Ig and H-2 allotypes, is found in the primary but not the secondary murine antibody response to lysozyme.
    M. A. Kaplan, M. A. Keller, D. H. Hsu, L. K. Ch'ng, A. Miller, E. E. Sercarz.
    European Journal of Immunology, Weinheim, October 1988, 18 (10): 1567-1574.

  • MRI of the floor of the mouth, tongue and orohypopharynx.
    E. E. Kassel, M. A. Keller, W. Kucharczyk.
    The Radiologic Clinics of North America, March 1989, 27 (2): 331-351. Review.

  • Primary response to lysozyme (HEL) and HEL-LPS in neonatal A/J mice: presence of characteristic adult pattern of regulatory idiotype and fine specificity restriction.
    M. A. Keller, M. A. Kaplan, N. S. Kenyon, A. Miller, E. E. Sercarz.
    Cellular Immunology, March 1989, 119 (1): 143-152.

  • Inhibition of offspring response to HEL-CFA by administration of anti-HEL MAB to the mother is not related to the predominant idiotype, IdXE, or specificity of the MAB.
    C. H. Song, G. B. Calandra, C. J. Palmer, A. Miller, E. E. Sercarz, M. A Keller.
    Cellular Immunology, December 1990, 131 (2): 311-324.

  • Modulation of the immune response by maternal antibody.
    M. A. Keller, C. J. Palmer, M. T. Jelonek, C. H. Song, A. Miller, E. E. Sercarz, G. B. Calandra, J. L. Brust.
    Advances in Experimental Medicine and Biology, New York, 1991, 310: 207-213.

  • Evidence for idiotypic sharing between conventional and naturally activated B cells.
    C. H. Song, G. B. Calandra, A. Miller, E. E. Sercarz, M. A Keller.
    European Journal of Immunology, Baltimore, September 1991, 21 (9): 2005-2010.

  • Subacute necrotizing myelopathy: MR imaging in four pathologically proved cases.
    D. R. Mirich, W. Kucharczyk, M. A. Keller, J. Deck.
    AJNR. American Journal of Neuroradiology, November-December 1991, 12 (6): 1077-1083.

  • Immunoglobulin G subclasses in human colostrum, milk and saliva.
    K. Kim, M. A. Keller, D. C. Heiner.
    Acta paediatrica, Oslo, February 1992, 81 (2): 113-118.

  • Characterization of the 5'-flanking transcriptional regulatory region of the human Fc gamma receptor gene, Fc gamma RIIA.
    S. E. McKenzie, M. A. Keller, D. L. Cassel, A. D. Schreiber, E. Schwartz, S. Surrey, E. F. Rappaport.
    Molecular Immunology, October 1992, 29 (10): 1165-1174.

  • Asymptomatic postendarterectomy dissection of the internal carotid artery detected incidentally on MRI.
    S. Aggarwal, W. Kucharczyk, M. A Keller.
    Neuroradiology, 1993, 35 (8): 586-587.

  • Differential expression of Fc gamma RIIA, Fc gamma RIIB and Fc gamma RIIC in hematopoietic cells: analysis of transcripts.
    D. L. Cassel, M. A. Keller, S. Surrey, E. Schwartz, A. D. Schreiber, E. F. Rappaport, S. E. McKenzie:
    Molecular Immunology, April 1993, 30 (5): 451-460.

  • Maternal HEL immunization has no lasting effects on the immune response of offspring to immunization with hen egg-white lysozyme.
    M. T. Jelonek, J. L. Brust, C. H. Song, G. B. Calandra, A. Miller, E. E. Sercarz, M. A Keller.
    Cellular Immunology, May 1993, 148 (2): 422-434.

  • A soluble form of the human Fc receptor Fc gamma RIIA: cloning, transcript analysis and detection.
    E. F. Rappaport, D. L. Cassel, D. O. Walterhouse, S. E. McKenzie, S. Surrey, M. A. Keller, A. D. Schreiber, E. Schwartz.
    Experimental Hematology, Copenhagen, May 1993, 21 (5): 689-696.

  • Fluorescence-based RT PCR analysis: determination of the ratio of soluble to membrane-bound forms of Fc gamma RIIA transcripts in hematopoietic cell lines.
    M. A. Keller, D. L. Cassel, E. F. Rappaport, S. E. McKenzie, E. Schwartz, S. Surrey.
    PCR Methods and Applications, Cold Spring Harbor, August 1993, 3 (1): 32-38.

  • Imaging quiz case 1. Metastatic cervical lymph nodes (LNs).
    S. Aggarwal, M. A Keller.
    Archives of Otolaryngology – Head & Neck Surgery, Chicago, February 1994, 120 (2): 222-225.

  • Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging.
    W. Kucharczyk, J. E. Bishop, D. B. Plewes, M. A. Keller, S. George.
    AJR. American Journal of Roentgenology, September 1994, 163 (3): 671-679.

  • Factors predictive of maternal-fetal transmission of HIV-1: A protective role for Zidovudine (ZDV) given during pregnancy and/or delivery.
    P. J. J. Boyer, M. Dillon, M. Navaie, A. Deveikis, M. A. Keller, S. O'Rourke, Y. J. Bryson.
    JAMA, 1994, 271: 1925-1930.

  • Rapid Increases in HIV-1 Load Correlate with Early Disease Progression and Loss of CD4 Cells in Vertically Infected Infants.
    Ruth E. Dickover, M. Dillon, S. G. Gillette, A. Deveikis, M. A. Keller, S. Plaeger-Marshall, I. Chen, A. Diagne, E. R. Stiehm, Y. Bryson.
    Journal of Infectious Diseases, 1994, 170: 1279-1284.

  • Lineage-specific alternative splicing of the human Fc gamma RIIA transmembrane exon requires sequences near the 3' splice site.
    M. A. Keller, S. E. McKenzie, D. L. Cassel, E. F. Rappaport, E. Schwartz, S. Surrey.
    Gene Expression, 1995, 4 (4-5): 217-225.

  • Postoperative carotid body tumor evaluation: analysis using MR angiography.
    J. Witterick, P. J. Gullane, M. A Keller.
    The Laryngoscope, July 1995, 105 (7 Pt 1): 764-767.

  • Correlation of Clinical Progression in Human Immunodeficiency Virus-Infected Children with In Vitro Zidovudine Resistance Measured by a Direct Quantitative Peripheral Blood Lymphocyte Assay.
    K. Nielsen, L. S. Wei, M. Sim, A. Deveikis, M. A. Keller, E. R. Stiehm, L. Frenkel, Y. J. Bryson.
    Journal of Infectious Diseases, 1995, 172 (2): 359-364.

  • Inhibition of the offspring anti-recombinant gp120 antibody response to a human immunodeficiency virus vaccine by maternal immunization in a murine model.
    M. T. Jelonek, J. L. Maskrey, K. S. Steimer, B. J. Potts, K. W. Higgins, M. A Keller.
    The Journal of Infectious Diseases, Chicago, August 1995, 172 (2): 539-542.

  • Maternal monoclonal antibody to the V3 loop alters specificity of the response to a human immunodeficiency virus vaccine.
    M. T. Jelonek, J. L. Maskrey, K. S. Steimer, B. J. Potts, K. W. Higgins, M. A Keller.
    The Journal of Infectious Diseases, Chicago, October 1996, 174 (4): 866-869.

  • Frequent Recurrence and Persistence of Varicella-Zoster-Virus (VZV) Infections in HIV-1 Infected Children.
    L. Von Seidlein, S. G. Gillette, Y. Bryson, T. Frederick,L. Mascola, J. Church, P. Brunell, A. Kovacks, A. Deveikis, M. A. Keller.
    Journal of Pediatrics, 1996, 128: 52-56.

  • Identification of levels of Maternal HIV-1 RNA associated with risk of perinatal transmission: Effect of maternal zidovudine treatment on viral load.
    R. E. Dickover, E. M. Garraty, S. A. Herman, M. Sim, S. Plaeger, P. J. Boyer, M. A. Keller, A. Deveikis, E. R. Stiehm, Y. J. Bryson.
    JAMA, 1996, 275 (8): 599-605.

  • Maternal Monoclonal Antibody to V-3 Loop Alters Specificity of the Response to a Human Immunodeficiency Virus Vaccine.
    M. T. Jelonek, J. L. Maskrey, K. S. Steimer, B. J. Potts, K. W. Higgins, M. A. Keller.
    Journal of Infectious Diseases, 1996, 174: 866-869.

  • HIV hyperimmune globulin or intravenous immune globulin inhibits response to an HIV vaccine.
    M. T. Jelonek, J. L. Maskrey, L. M. Cummins, Y. Arora, K. S. Steimer, M. White-Scharf, M. A Keller.
    Biotechnology and Applied Biochemistry, April 1998, 27 (p 2): 89-95.

  • Reoperative parathyroidectomy in the era of localization technology.
    L. Rotstein, J. Irish, P. Gullane, M. A. Keller, K. Sniderman.
    Head & Neck, New York, September 1998, 20 (6): 535-539.

  • Human Immunodeficiency Virus Hyperimune Globulin (HIVIG) or Intravenous Immune Globulin (IVIG) Inhibits Response to an HIV Vaccine.
    M. T. Jelonek, J. L. Maskrey, L. J. Cummins, Y. Arora, K. S. Steimer, M. White-Scharf, M. A. Keller.
    Biotechnology and Applied Biochemistry, 1998, 27: 89-95.

  • Early Prognostic Indicators in Primary Perinatal Human Immunodeficiency Virus Type 1 Infection: Importance of Viral RNA and the Timing of Transmission on Long-Term Outcome.
    R. E. Dickover, M. Dillon, K. M. Leung, Korgstad, P., S. Plaeger, S. Kwok, C. Christopherson, A. Deveikis, M. A. Keller, E. R. Stiehm, Y. J. Bryson.
    The Journal of Infectious Diseases, 1998, 178: 375-87.

  • Inhibition of the anti-V3 loop response to a recombinant gp120SF2 vaccine by preexisting monoclonal antibody.
    M. A. Keller, Y. Arora.
    AIDS Research and Human Retroviruses, Larchmont, June 10, 1999, 15 (9): 855-860.

  • A prospective, blinded comparison of clinical examination and computed tomography in deep neck infections.
    W. D. Miller, I. M. Furst, G. K. Sāndor, M. A Keller.
    The Laryngoscope, November 1999, 109 (11): 1873-1879.

  • Netprints: the next phase in the evolution of biomedical publishing.
    T. Delamothe, R. Smith, M. A. Keller, J. Sack, B. Witscher.
    BMJ, London, December 11, 1999, 319 (7224): 1515-1516.

  • The genetic contribution of single male immigrants to small, inbred populations: a laboratory study using Drosophila melanogaster.
    S. J. Ball, M. Adams, H. P. Possingham, M. A Keller.
    Heredity, June 2000, 84 (Pt 6): 677-684.

  • Passive immunity in prevention and treatment of infectious diseases.
    M. A. Keller, E. R. Stiehm.
    Clinical Microbiology Reviews, Washington, October 2000, 13 (4): 602-614. Review.

  • A Parapharyngeal abscess due to cat scratch disease.
    S. H. Yeh, K. M. Zangwill, B. Hall, L. McPhaul, M. A. Keller.
    Clinical Infectious Disease, 30:599-601, 2000.

  • Pneumococcal and Influenza Immunization and HIV Viral Load in Children.
    M. A. Keller, A. Deveikis, M. Cutillar-Garcia, A. Gagajena, K. Elkins, S. Plaeger, S-J. Chang, Y. Bryson, A. Kaplan, K. Zangwill
    Pediatric Infectious Diseases Journal, 2000, 19: 613-618.

  • RNA replication from the simian virus 5 antigenomic promoter requires three sequence-dependent elements separated by sequence-independent spacer regions.
    M. A. Keller, S. K. Murphy, G. D. Parks.
    Journal of Virology, April 2001, 75 (8): 3993-3998.

  • Trophic barriers to fertilizer Cd bioaccumulation through the food chain: a case study using a plant--insect predator pathway.
    G. Merrington, D. Miller, M. J. McLaughlin, M. A Keller.
    Archives of Environmental Contamination and Toxicology, August 2001, 41 (2): 151-156.

  • Breast milk transmission of viral disease.
    E. R. Stiehm, M. A Keller.
    Advances in Nutritional Research, New york, 2001, 10: 105-122. Review.

  • Visual outcomes following macular translocation with 360-degree peripheral retinectomy.
    J. C. Lai, D. J. Lapolice, S. S. Stinnett, C. H. Meyer, L. M. Arieu, M. A. Keller, C. A. Toth.
    Archives of Ophthalmology, Chicago, October 2002, 120 (10): 1317-124.

  • Use of hydroxyurea and recombinant erythropoietin in management of homozygous beta0 thalassemia.
    M. Kohli-Kumar, H. Marandi, M. A. Keller, K. Guertin, E. Hvizdala.
    Journal of Pediatric Hematology/Oncology, December 2002, 24 (9): 777-778.

  • Positive- and negative-acting signals combine to determine differential RNA replication from the paramyxovirus simian virus 5 genomic and antigenomic promoters.
    M. A. Keller, G. D. Parks.
    Virology, February 15, 2003, 306 (2): 347-358.

  • K. W. Purdy, J. R. Heckenlively, J. A. Church, M. A Keller.
    Progressive outer retinal necrosis caused by varicella-zoster virus in children with acquired immunodeficiency syndrome.

    The Pediatric Infectious Disease Journal, Baltimore, April 2003, 22 (4): 384-386. Review.

  • Is delayed operative treatment worth the trouble with perforated appendicitis is children?
    T. R. Weber, M. A. Keller, R. J. Bower, G. Spinner, K. Vierling.
    The American Journal of Surgery, December 2003, 186 (6): 685-688; discussion 688-689.

  • Progressive outer retinal necrosis caused by varicella-zoster virus in children with acquired immunodeficiency syndrome.
    K. W. Purdy, J. R. Heckenlively, J. A. Church, M. A Keller.
    The Pediatric Infectious Disease Journal, Baltimore, April 2003, 22 (4): 384-386. Review.

  • Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests.
    M. A. Keller, T. N. Venkatraman, A. Thomas, A. Deveikis, C. LoPresti, J. Hayes, N. Berman, I. Walot, S. Padilla, J. Johnston-Jones, T. Ernst, L. Chang.
    Neurology, May 25, 2004, 62 (10): 1810-1817.

  • Erythroid-induced commitment of K562 cells results in clusters of differentially expressed genes enriched for specific transcription regulatory elements.
    S. Addya, M. A. Keller, K. Delgrosso, C. M. Ponte, R. Vadigepalli, G. E. Gonye, S. Surrey.
    Physiological Genomics, Bethesda, September 16, 2004, 19 (1): 117-130.

  • Changing Pattern of AIDS: A bone marrow study.
    X. Zhao, N. C. J. Sun, M. D. Witt, M. A. Keller, and Y. Niihara.
    American Journal of Clinical Pathology, 2004, 121: 393-401.

  • Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation.
    M. A. Keller, J. Martinez, T. C. Baradet, C. Nagaswami, I. N. Chernysh, M. K. Borowski, S. Surrey, J. W. Weisel.
    Blood, April 15, 2005, 105(8):3162-8.

  • Molecular diagnostic testing for inherited thrombophilia using Invader.
    M. A Keller.
    Methods in Molecular Medicine, Totowa, N.J., 2005, 114: 107-119.

  • Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life.
    M. Mirochnick, A. Stek, M. Acevedo, M. A. Keller, D. Holland, E. Capparelli, J. Connor, M. S. Huang, M. Hughes, H. Watts, L. Mofenson, L., Y. Bryson.
    Journal of Acquired Immune Deficiency Syndromes, June 1, 2005, 39 (2): 189-194.

  • Cerebral metabolites in HIV-infected children followed for 10 months with 1H-MRS.
    M. A. Keller, T. N. Venkatraman, M. A. Thomas, A. Deveikis, C. LoPresti, J. Hayes, N. Berman, I. Walot, T. Ernst, L. Chang.
    Neurology, March 28, 2006, 66 (6): 874-879.

  • The ComPact UniLock 2.0/2.4 system and its clinical application in small animal orthopedics.
    M. A. Keller, K. Voss, P. M. Montavon.
    Veterinary and Comparative Orthopaedics and Traumatology, 2005, 18 (2): 83-93. Review.

  • Increased tomato yield through pollination by native Australian Amegilla chlorocyanea (Hymenoptera: Anthophoridae).
    K. Hogendoorn, C. L. Gross, M. Sedgley, M. A Keller.
    Journal of Economic Entomology, College Park, Maryland, June 2006, 99(3):828-33.

  • Transcriptional regulatory network analysis of developing human erythroid progenitors reveals patterns of coregulation and potential transcriptional regulators.
    M. A. Keller, S. Addya, R. Vadigepalli, B. Banini, K. Delgrosso, H. Huang, S. Surrey.
    Physiological Genomics, Bethesda, December 13, 2006, 28 (1): 114-128.

  • Magnetic resonance imaging assessment of airway status after orthognathic surgery.
    T. Meisami, M. Musa, M. A. Keller, R. Cooper, C. M. Clokie, G. K. Sāndor.
    Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, St. Louis, April 2007, 103 (4): 458-463.

  • Topology of the global regulatory network of carbon limitation in Escherichia coli.
    T. Hardiman, K. Lemuth, M. A. Keller, M. Reuss, M. Siemann-Herzberg.
    Journal of Biotechnology, Amsterdam, December 1, 2007, 132 (4): 359-374.

  • Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery.
    K. Gwinn, R. A. Corriveau, H. Mitsumoto, K. Bednarz, R. H. Brown Jr, M. Cudkowicz, P. H. Gordon, J. Hardy, E. J. Kasarskis, P. Kaufmann, R. Miller, E. Sorenson, R. Tandan, B. J. Traynor, J. Nash, A. Sherman, M. D. Mailman, J. Ostell, L. Bruijn, V. Cwik, S. S. Rich, A. Singleton, L. Refolo, J. Andrews, R. Zhang, R. Conwit, M. A. Keller; ALS Research Group:
    PLoS ONE, december 5, 2007, 2 (12): e1254.

  • Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.
    S. Banakar, M. A. Thomas, A. Deveikis, J. Q. Watzl, J. Hayes, M. A Keller.
    Journal of Magnetic Resonance Imaging, New York, April 2008, 27 (4): 710-717.

  • Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.
    S. Banakar, M. A. Thomas, A. Deveikis, J. Q. Watzl, J. Hayes, M. A Keller.Journal of Magnetic Resonance Imaging, New York, April 2008, 27 (4): 710-717.

  • The effect of resource aggregation at different scales: optimal foraging behavior of Cotesia rubecula.
    B. Tenhumberg, M. A. Keller, A. J. Tyre, H. P. Possingham.
    The American Naturalist, Chicago, November 2001, 158 (5): 505-518.

  • Preparation and use of therapeutic antibodies primarily of human origin.
    E. R. Stiehm, M. A. Keller, G. N. Vyas.
    Biologicals, November 2008, 36 (6): 363-374.

  • Global transcription and metabolic flux analysis of Escherichia coli in glucose-limited fed-batch cultivations.
    K. Lemuth, T. Hardiman, S. Winter, D. Pfeiffer, M. A. Keller, S. Lange, M. Reuss, R. D. Schmid, M. Siemann-Herzberg.
    Applied and Environmental Microbiology, Washington DC., November 2008, 74 (22): 7002-7015.

  • Pharmacokinetics and Safety of Nelfinavir When Used in Combination with Zidovudine and Lamivudine in HIV-Infected Pregnant Women.
    Y. J. Bryson, M. Mirochnick, A. Stek, L. M. Mofenson, J. Connor, E. Capparelli, D. H. Watts, S. Juang, M. D. Hughes, K. Kaiser, L. Purdue, Y. Asfaw, M. A. Keller, M. and E. Smith for the PACTG 353 Team.
    Pediatric AIDS clinical Trials Group (PACTG) Protocol 353. HIV Clinical Trials, In press (by early 2009).



 
 

Last names on A Last names on B Last names on C Last names on D Last names on E Last names on F Last names on G Last names on H Last names on I Last names on J Last names on K Last names on L Last names on M Last names on N Last names on O Last names on P Last names on Q Last names on R Last names on S Last names on T Last names on U Last names on V Last names on W Last names on X Last names on Y Last names on Z Last names on Æ Last names on S Last names on T